Orion OYJ (ORINY) Stock Price, News & Analysis

Company Overview

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.

The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas. Orion is also known for products such as the Easyhaler inhaler platform and medicines used in the treatment of Parkinson’s disease. Its animal-health business provides veterinary medicines for companion animals and livestock.

Founded in Finland in 1917, Orion conducts pharmaceutical research, product development and manufacturing in Finland and serves customers through international operations and partnerships. The company markets its products in Finland and in numerous other countries, working with healthcare professionals, pharmacies, hospitals and pharmaceutical partners.

Key Stats

• Today's Range: $46.65 to $46.65
• 50-Day Range: $43.02 to $48.79
• 52-Week Range: $30.89 to $48.79
• Volume: 275 shs
• Average Volume: 1,575 shs
• Market Capitalization: $13.17 billion
• P/E Ratio: 19.20
• Dividend Yield: 0.81%
• Price Target: N/A
• Consensus Rating: Hold

Orion OYJ Stock Analysis - MarketRank™

Orion OYJ scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Orion OYJ has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Orion OYJ has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orion OYJ is 19.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.86.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orion OYJ is 19.20, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.56.

Price to Book Value per Share Ratio

Orion OYJ has a P/B Ratio of 9.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.00% of the float of Orion OYJ has been sold short.

Short Interest Ratio / Days to Cover

Orion OYJ has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Orion OYJ has recently increased by 157.84%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Orion OYJ has a dividend yield of 0.82%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orion OYJ does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orion OYJ is 15.64%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.05

News Sentiment

Orion OYJ has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Orion OYJ this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orion OYJ insiders have not sold or bought any company stock.

Percentage Held by Institutions

Orion OYJ has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/17/2026
• Today: 10/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ORINY
• Previous Symbol: NASDAQ:ORINY
• CIK: N/A
• Web: www.orion.fi
• Phone: 358 10 4261
• Fax: N/A
• Employees: 4,029
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.43
• Trailing P/E Ratio: 19.20
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $566.04 million
• Net Margins: 28.52%
• Pretax Margin: 35.39%
• Return on Equity: 50.37%
• Return on Assets: 30.65%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 2.64
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $2.14 billion
• Price / Sales: 6.16
• Cash Flow: $2.27 per share
• Price / Cash Flow: 20.56
• Book Value: $5.15 per share
• Price / Book: 9.06

Miscellaneous

• Outstanding Shares: 282,270,000
• Free Float: N/A
• Market Cap: $13.17 billion
• Optionable: Not Optionable
• Beta: 0.07